Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)2 receptor agonist-induced increases in rat serum corticosterone concentrations: Evidence for 5-HT2A receptor mediation of the HPA axis

Neuropharmacology

Volumn 42, Issue 2, 2002, Pages 162-169

  Hemrick Luecke, Susan K ^a   Evans, David C ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

5 HT2A 2C receptors; Corticosterone concentrations; DOI; m CPP; MDL 100,907; Quipazine; Ro 60 0175; SB 242084

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; CORTICOSTERONE; QUIPAZINE; RECEPTOR SUBTYPE; SEROTONIN 2 AGONIST; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR;

ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINOPYRIDINES; AMPHETAMINES; ANIMALS; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHYLAMINES; FLUOROBENZENES; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INDOLES; MALE; PIPERAZINES; PIPERIDINES; QUIPAZINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0036166909     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(01)00166-6     Document Type: Article

References (61)

1. Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat
2. Effects of various serotonin receptor subtype selective antagonists alone and on m-CPP-induced neuroendocrine changes in rats
3. 2C receptors, respectively
4. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats
5. 2 receptor stimulation on excessive grooming, penile erections and plasma oxytoxin concentrations
6. 2C receptor-mediated oxytoxin, prolactin and ACTH/corticosterone responses
7. 1C receptors in drug-induced penile erections in rats
8. 2C receptors. Synthesis and biological evaluation of substituted 2-(indol-1-yl)-methylethylamines and 2-(indenol[1,2-b]pyrrol-1-(indol-1-yl)methylethylamines. Improved therapeutics for obsessive compulsive disorder
9. 2C receptor antagonist
10. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat
11. 2C receptor agonist and d-fenfluramine on feeding patterns in the rat
12. 2B receptor protein in the rat central nervous system
13. The effect of quipazine, a serotonin receptor agonist on serum corticosterone in rats
14. Central serotonin antagonist activity of ketanserin
15. Serotonin receptor subtypes involved in the elevation of serum corticosterone concentration in rats by direct- and indirect-acting serotonin agonists
16. The involvement of serotonin in regulation of pituitary-adrenocortical function
17. Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats
18. 1A receptor subtype increases rat plasma ACTH concentration
19. Quipazine: Its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity and behaviour
20. 2C receptor mediated behaviors with selective antagonists
21. 2 receptor subtype antagonists in rat and mouse models of anxiety
22. 1-m-(chlorophenyl)piperazine (m-CPP) interactions with neurotransmitter receptors in the human brain
23. The molecular biology of serotonin receptors
24. 2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212
25. 2 receptors
26. 2C receptor antagonist SB242,084 on behavior produced by the 5-HT2 agonist Ro 60-0175 and the indirect 5-HT agonist dexfenfluramine
27. 3H]ketanserin
28. 1B recognition sites
29. 1 recognition sites
30. 1C receptor-mediated stimulation of inositol phosphate production in pig choroid plexus. A pharmacological characterization
31. VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine
32. 2C receptor agonists and fluoxetine in a model of panic-like anxiety in rats
33. Adrenocorticotropic hormone secretion in rats induced by stimulation with serotonergic compounds
34. m-Chlorophenylpiperazine as a probe of serotonin function
35. 2A antagonist with a favorable CNS safety profile
36. 2C receptors
37. 1C receptor antagonists
38. 1C receptors and their therapeutic relevance
39. 2C receptor antagonist
40. 2C receptor agonist, in three animal models of anxiety
41. 1C receptor subtype
42. Stimulation of corticosterone and β-endorphin secretion in the rat by selective 5-HT receptor subtype activation
43. 2 receptor binding sites
44. Synaptic interactions of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study
45. 2) agonists and antagonists on renin and corticosterone secretion
46. Effect of 1-(m-chloro-phenyl)piperazine and 1-(m-trifluroromethylphenyl)piperazine on locomotor activity
47. Quipazine-induced head-twitch in mice
48. 2C receptor agonists and antagonists in animal models of anxiety
49. 2C receptor agonists: Pharmacological characteristics and therapeutic potential
50. Repeated administration of meta-chlorophenylpiperazine or 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane produces tolerance to its stimulatory effect on adrenocorticotropin hormone but not prolactin or corticosterone secretion in rats
51. 2C receptors mediate penile erections in rats: Actions of novel and selective agonists and antagonists
52. 2C receptors
53. 5-Hydroxytryptamine receptor subtypes
54. Serotonin receptor subtypes mediating neuroendocrine responses to DOI
55. 2A/2C) receptors
56. 1A agonists
57. 2A receptors
58. Corticotropin-releasing hormone
59. Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications
60. Neurotransmitter regulation of anterior pituitary hormones
61. Neuroendocrine pharmacology of serotonergic (5HT) neurons